Nonclinical Development of Biological, Small Molecules and Combination Products

Our consulting company provides nonclinical, scientific, and regulatory services for biological, small molecules, and combination products, including medical devices. Our company focuses on nonclinical development of regenerative medicine, cell and gene therapies, monoclonal antibodies, biosimilars, protein and bi-specific therapeutics, and nanotherapeutics.

AdvancedBio Consulting specializes in drug, biologic, and delivery devices, including novel drug-biologic delivery platforms. These include 3D bioprinted scaffolds and matrices; hydrogels; implantable biodegradable, nonbiodegradable, and simple delivery devices; and safety assessments, including biocompatibility strategy and design and implementation for acute, subchronic, and chronic use.